{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:59:26Z","timestamp":1792483166146,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116216","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T12:33:43Z","timestamp":1632746023000},"page":"116216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: A nationwide population study"],"prefix":"10.1016","volume":"154","author":[{"given":"Ta-Wei","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116216_bb0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.berh.2005.06.003","article-title":"How many people develop fractures with what outcome?","volume":"19","author":"O\u2019Neill","year":"2005","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bone.2021.116216_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1532-5415.2000.tb02647.x","article-title":"Mortality and institutionalization following hip fracture","volume":"48","author":"Cree","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2021.116216_bb0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.6061\/clinics\/2012(06)02","article-title":"Early interdisciplinary hospital intervention for elderly patients with hip fractures: functional outcome and mortality","volume":"67","author":"Tarazona-Santabalbina","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.bone.2021.116216_bb0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S8756-3282(03)00061-9","article-title":"The components of excess mortality after hip fracture","volume":"32","author":"Kanis","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116216_bb0025","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","article-title":"Excess mortality following hip fracture: a systematic epidemiological review","volume":"20","author":"Abrahamsen","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116216_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2014.02.016","article-title":"Mortality following the first hip fracture in Norwegian women and men (1999\u20132008). A NOREPOS study","volume":"63","author":"Omsland","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116216_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.injury.2015.11.018","article-title":"National audits of hip fractures: are yearly audits required?","volume":"47","author":"Ferguson","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.bone.2021.116216_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00004148","article-title":"World-wide projections for hip fracture","volume":"7","author":"Gullberg","year":"1997","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116216_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/injuryprev-2016-042192","article-title":"Functioning and health-related quality of life following injury in older people: a systematic review","volume":"23","author":"Brown","year":"2017","journal-title":"Inj. Prev."},{"key":"10.1016\/j.bone.2021.116216_bb0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijsu.2018.02.061","article-title":"Preventable risk factors of mortality after hip fracture surgery: systematic review and meta-analysis","volume":"52","author":"Chang","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bone.2021.116216_bb0060","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.injury.2018.04.007","article-title":"Pre-operative factors associated with increased mortality in elderly patients with a hip fracture: a cohort study in a developing country","volume":"49","author":"Espinosa","year":"2018","journal-title":"Injury"},{"issue":"Suppl. 4","key":"10.1016\/j.bone.2021.116216_bb0065","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.injury.2016.07.055","article-title":"Prognostic factors for mortality after hip fracture: operation within 48\u00a0hours is mandatory","volume":"47","author":"Rosso","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.bone.2021.116216_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1302\/0301-620X.97B3.34504","article-title":"The determinants of mortality and morbidity during the year following fracture of the hip: a prospective study","volume":"97-B","author":"Mariconda","year":"2015","journal-title":"Bone Joint J."},{"key":"10.1016\/j.bone.2021.116216_bb0075","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/gerona\/58.11.M1042","article-title":"Time to ambulation after hip fracture surgery: relation to hospitalization outcomes","volume":"58","author":"Kamel","year":"2003","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bone.2021.116216_bb0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archinte.166.7.766","article-title":"Early ambulation after hip fracture: effects on function and mortality","volume":"166","author":"Siu","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0085","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116216_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1359\/jbmr.090704","article-title":"Potential mediators of the mortality reduction with zoledronic acid after hip fracture","volume":"25","author":"Colon-Emeric","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116216_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00198-003-1516-y","article-title":"Excess mortality after hospitalisation for vertebral fracture","volume":"15","author":"Kanis","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116216_bb0100","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archinte.1996.00440130053006","article-title":"Mortality following fractures in older women. The study of osteoporotic fractures","volume":"156","author":"Browner","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00198-003-1412-5","article-title":"Incident vertebral fractures and mortality in older women: a prospective study","volume":"14","author":"Kado","year":"2003","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116216_bb0110","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/jbmr.3216","article-title":"Mortality after osteoporotic fractures: what proportion is caused by fracture and is preventable?","volume":"32","author":"Schousboe","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116216_bb0115","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture prevention with zoledronate in older women with osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0120","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1210\/jc.2015-3467","article-title":"Preadmission bisphosphonate and mortality in critically ill patients","volume":"101","author":"Lee","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116216_bb0125","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0130","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.bone.2021.116216_bb0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12877-019-1278-9","article-title":"Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.bone.2021.116216_bb0140","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1532-5415.2010.02769.x","article-title":"Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture","volume":"58","author":"Jennings","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2021.116216_bb0145","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.smj.0000221637.90495.66","article-title":"Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting","volume":"99","author":"Downey","year":"2006","journal-title":"South. Med. J."},{"key":"10.1016\/j.bone.2021.116216_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.189","article-title":"Estimating bisphosphonate use and fracture reduction among US women aged 45\u00a0years and older, 2001\u20132008","volume":"26","author":"Siris","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116216_bb0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00774-014-0621-7","article-title":"Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients","volume":"33","author":"Hsu","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2021.116216_bb0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.injury.2018.01.003","article-title":"Baseline and pre-operative 1-year mortality risk factors in a cohort of 509 hip fracture patients consecutively admitted to a co-managed orthogeriatric unit (FONDA Cohort)","volume":"49","author":"Menendez-Colino","year":"2018","journal-title":"Injury"},{"key":"10.1016\/j.bone.2021.116216_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15020289","article-title":"Incidence rates of and mortality after hip fracture among German nursing home residents","volume":"15","author":"Jacobs","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bone.2021.116216_bb0170","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/acr.21759","article-title":"Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data","volume":"64","author":"Curtis","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.bone.2021.116216_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bone.2015.04.032","article-title":"Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival\u2014a nationwide study of the Swedish population 60\u00a0years and older","volume":"78","author":"Karampampa","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116216_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13018-019-1226-6","article-title":"Mortality after osteoporotic hip fracture: incidence, trends, and associated factors","volume":"14","author":"Guzon-Illescas","year":"2019","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bone.2021.116216_bb0185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00198-003-1430-3","article-title":"Mortality and morbidity associated with osteoporosis drug treatment following hip fracture","volume":"14","author":"Cree","year":"2003","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116216_bb0190","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00198-010-1411-2","article-title":"Oral bisphosphonates are associated with reduced mortality after hip fracture","volume":"22","author":"Beaupre","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116216_bb0195","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.116216_bb0200","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jamainternmed.2019.2779","article-title":"Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis","volume":"179","author":"Cummings","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0205","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/stem.2255","article-title":"Zoledronate attenuates accumulation of DNA damage in mesenchymal stem cells and protects their function","volume":"34","author":"Misra","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.bone.2021.116216_bb0210","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2021.116216_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arr.2007.03.002","article-title":"Hormesis in aging","volume":"7","author":"Rattan","year":"2008","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bone.2021.116216_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2016.06.039","article-title":"Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis","volume":"252","author":"Kranenburg","year":"2016","journal-title":"Atherosclerosis"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:46:03Z","timestamp":1762659963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":44,"alternative-id":["S8756328221003823"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116216","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: A nationwide population study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116216"}}